IKT Competitors & Alternatives

Compare Inhibikase Therapeutics Inc with similar stocks in the same industry

Biotechnology

IKT

Main Stock
$1.52
-0.65%
Tradestie Score
48
Market Cap
$119.97M
Revenue Growth
-100.0%
Analyst Upside
+294.7%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: c-Abl kinase inhibition, Small-molecule design
Major Customers 3
Academic research institutions NIH Clinical trial sites
Critical Suppliers 3
CROs CMOs API manufacturers
Direct Ecosystem Rivals 3

Top Competitors

222 stocks in Biotechnology
Company Price Market Cap P/E Score Action
VOR Vor Biopharma Inc. Common Stock
$19.42
+0.52%
$269.08M 0.1 42 Compare
VYGR Voyager Therapeutics, Inc. Common Stock
$1.73
+1.76%
$259.59M - 42 Compare
VTYX Ventyx Biosciences, Inc. Common Stock
$14.00
+0.14%
$256.71M - 51 Compare
SLN Silence Therapeutics Plc American Depository Share
$19.83
+0.15%
$240.89M - 42 Compare
OABI OmniAb, Inc. Common Stock
$4.91
-0.81%
$231.77M - 48 Compare
SGMT Sagimet Biosciences Inc. Series A Common Stock
$10.22
-6.50%
$227.00M - 47 Compare
SLS SELLAS Life Sciences Group, Inc. Common Stock
$7.86
-2.12%
$211.22M - 63 Compare
ACRS Aclaris Therapeutics, Inc.
$3.92
-2.00%
$202.58M - 38 Compare
CBIO Crescent Biopharma, Inc. Common Stock
$14.15
-1.53%
$199.71M - 37 Compare
FBRX Forte Biosciences, Inc. Common Stock
$76.99
+0.03%
$180.53M - 54 Compare

Data updated: Nov 15, 2026 | Industry: Biotechnology (SIC 2836)

222 stocks in this industry